Pharma Reviews: Hyderabad's IICT can reverse engineer COVID-19 drug in 3 months

In case the pharmaceutical companies refuse to sell or share the drug technology in India, Parliament has the right to invoke 'compulsory licensing' ...
Read more: Hyderabad's IICT can reverse engineer COVID-19 drug in 3 months